The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...

The complaint alleges nearly two dozen pharmaceutical companies colluded to limit competition, causing costs for certain ...

After hours: January 17 at 7:34:42 PM EST ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Teva's long haul to a turnaround of its business ... and saddled with debt from its takeover of generics business Actavis. Since then, newer new drugs Austedo (deutetrabenazine) for Huntington's ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

1 Day TEVA 1.11% DJIA 0.78% S&P 500 1.00% Health Care/Life Sciences 66.70% ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.